Click to search

Novel therapies for hepatitis C - one pill fits all?

Authors

Manns MP1, von Hahn T.
Author information
  • 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany. manns.michael@ mh-hannover.de

Journal

Nat Rev Drug Discov. 2013 Aug;12(8):595-610. doi: 10.1038/nrd4050. Epub 2013 Jun 28.

Affiliation

Abstract

Almost 25 years after the hepatitis C virus (HCV) was identified, and following intense research and development efforts, a large number of direct-acting antiviral drugs are now beginning to reach patient care. Accordingly, the way in which care is delivered is evolving at a breath-taking pace. Here, we review the current and upcoming treatment options for HCV, describe the key challenges facing clinicians and drug developers and discuss how the landscape in the HCV arena will change over the coming years.

PMID

23807378 [PubMed - indexed for MEDLINE]
Nature Publishing Group: Full text
 Citation 2 of 3875 Back to results 
Standard PubMed